Citation Impact
Citing Papers
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
“Weathering” and Age Patterns of Allostatic Load Scores Among Blacks and Whites in the United States
2005 Standout
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
2011 Standout
Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
2009
Epidemiology and causes of preterm birth
2008 Standout
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
2006
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
Acromegaly
2006 Standout
Randomized placebo‐controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy
2001
Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
2010
Effects of Testosterone Replacement in Hypogonadal Men1
2000
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Serum concentrations of sex hormone binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus,,
2002
Spinal-cord injury
2002 Standout
Cushing's syndrome
2001
Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans.
1994
Free insulin-like growth factors in human obesity
1995
Cushing's syndrome
2015 Standout
Peptide Signaling in Human Placenta and Membranes: Autocrine, Paracrine, and Endocrine Mechanisms*
1996
Cholinergic control of growth hormone (GH) responses to GH‐releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback
1993
Phaeochromocytoma
2005 Standout
Position Stand on Androgen and Human Growth Hormone Use
2009
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Effects of Transdermal Testosterone on Lipids and Vascular Reactivity in Older Men With Low Bioavailable Testosterone Levels
2002
Melatonin and the pituitary‐thyroid axis status in blind adults: a possible resetting after puberty
1995
Alterations in the Pulsatile Mode of Growth Hormone Release in Men and Women with Insulin-Dependent Diabetes Mellitus*
1989
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
2013
Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies
2004
Effects of metformin and ethinyl estradiol–cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome
2005
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
2011
High Prevalence of Polycystic Ovaries and Associated Clinical, Endocrine, and Metabolic Features in Women with Previous Gestational Diabetes Mellitus
1998
Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus
1997
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables
1994
HORMONES AND HYPERTENSION
1989
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
1994
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
2010
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-aged Men: Prospective Results from the Massachusetts Male Aging Study
2001
Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II diabetic patients
1994
CORTISOL AND HYPERTENSION
1998
Aging‐Related Decline of Gonadal Function in Healthy Men: Correlation with Body Composition and Lipoproteins
2000
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Polycystic Ovary Syndrome
2005 Standout
Subclinical Thyroid Disease
2004 Standout
Variability in the growth hormone response to growth hormone-releasing hormone alone or combined with pyridostigmine in type 1 diabetic patients
1993
Hypothalamic Mediation of Reduced GH Secretion in Diabetic Rats: Evidence for Reduced Cholinergic Inhibition of Somatostatin Release
1995
Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome
2001
Polycystic Ovary Syndrome
2004
The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures
2002
Incidentally Discovered Adrenal Masses*
1995
Effect of acute high dose dobutamine administration on serum thyrotrophin (TSH)
1999
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries
2009
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Adverse Lipid and Coronary Heart Disease Risk Profiles in Young Women with Polycystic Ovary Syndrome: Results of a Case-Control Study
1998
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)
2005
Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age
2001
Cushing's syndrome
2006 Standout
Obesity and the polycystic ovary syndrome
2002
Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
2015 Standout
Polycystic ovary syndrome
2016 Standout
Growth hormone neuroregulation in diabetes mellitus
1994
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Stress and Preterm Birth: Neuroendocrine, Immune/Inflammatory, and Vascular Mechanisms
2001
Hypothalamic control of growth hormone (GH) secretion in type i diabetic men: Effect of the combined administration of gh-releasing hormone and hexarelin, a novel GHRP-6 analog.
1996
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Long-term health consequences of PCOS
2002
Polycystic Ovarian Syndrome (PCOS): A Significant Contributor to The Overall Burden of Type 2 Diabetes in Women
2007
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with Troglitazone
2003
Testosterone and obesity
2015
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
A More Atherogenic Serum Lipoprotein Profile Is Present in Women with Polycystic Ovary Syndrome: A Case-Control Study
2007
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Adrenocortical carcinomas: surgical trends and results of a 253‐patient series from the French Association of Endocrine Surgeons study group
2001
Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
2003
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
1995
Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase
2001
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Adrenal cortical carcinoma
2001
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome
2004
Androgens and Coronary Artery Disease
2003
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
The association of hypotestosteronemia with coronary artery disease in men.
1994
Cushing’s Syndrome and Hypertension
1994
Clinical results of the use of mitotane for adrenocortical carcinoma
2000
Metabolic Changes in Persons After Spinal Cord Injury
2000
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
1995
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
The Metabolic Syndrome
2008 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Adrenocortical Carcinoma
2013
Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women
2000
Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
1996
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia
2010
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
1996
Works of S Zgliczyński being referenced
Transdermal 17β-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-l in postmenopausal women
1992
The circadian rhythm of melatonin in hypothyroidism and hyperthyroidism
1988
Endogenous natriuretic factors: atrial natriuretic hormone and digitalis-like substance in Cushing's syndrome
1991
Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction
1989
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome
1991
Short term pirenzepine treatment is ineffective in suppressing 24-h growth hormone secretion in type 1 diabetes mellitus
1993
Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus
1988
Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension
1990
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease
1995
Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men
1996
Increased Activity of Digoxin-Like Substance in Low-Renin Hypertension in Acromegaly
1990
[Serum estradiol level in men with acute myocardial infarction].
1986
Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour.
1987
[Studies on the pathogenesis of arterial hypertension in acromegaly. I. The renin-angiotensin-aldosterone system].
1983
Evidence for α-adrenergic receptors mediated TSH release in men
1980
Adrenocortical carcinoma. A clinical study and treatment results of 52 patients
1995
The role of sex hormones in the mechanism of inhibited LH release in female patients with anorexia nervosa
1982
An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
1992
[The influence of testosterone replacement therapy on well-being, bone mineral density and lipids in elderly men].
1998
Arterial Hypertension in Acromegaly: Altered Dopaminergic Control of Aldosterone Secretion
1987
High Blood Pressure and Hyperinsulinaemia in Acromegaly and in Obesity
1989